Abbas E. Kitabchi, PHD, MD, Guillermo E. Umpierrez, MD, Mary Beth Murphy, RN, MS, CDE, MBA, Eugene J. Barrett, MD, PHD, Robert A. Kreisberg, MD, John I. Malone, MD ...

5-hydroxytriptamine is a key mediator in the pathogenesis of migraine and thus 5-HT 1-receptor agonists are the principal drugs for acute migraine therapy. There are three classes of drugs for ...